What is the Impact Factor of Ceska a Slovenska Farmacie?

The journal Ceska a Slovenska Farmacie is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Ceska a Slovenska Farmacie indexed in Web of Science or Scopus?

Yes, Ceska a Slovenska Farmacie is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.162 (Q4) and an H-index of 19.

Who publishes Ceska a Slovenska Farmacie and what is the Article Processing Charge (APC)?

Ceska a Slovenska Farmacie is published by Nakladatelske Stredisko CLSJE Purkyne. The estimated Article Processing Charge (APC) is approximately $2,362 USD, subject to institutional waivers and corresponding author affiliations.

WoS SCIE Q1Scopus Q4SCImago #24,477Subscription

Ceska a Slovenska Farmacie

Identifier (ISSN):1210-7816(Print)/1805-4439(Online)

•

Publisher:Nakladatelske Stredisko CLSJE Purkyne

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Ceska a Slovenska Farmacie

WoS Q1

Annual Impact Factor Metric

Current (2023):0

Scopus SJR & RankScopus Q4

0.162

#24,477

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

19 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessSubscription

0articles/year

0% Gold OA•0% Original Research

Aims & Scope

Přehledový článek je zaměřen zejména na metody přípravy, charakterizaci mikročástic a dále na charakteristiku a příklady jejich možného využití ve farmakoterapii. Mikročástice jako...

Topics Covered (Recognized by AI)

Biology81.8%Medicine75.5%Chemistry73.6%Organic chemistry56%Biochemistry50.7%Physics42.4%Pharmacology38.9%Internal medicine34.3%Genetics34.2%Chromatography31.2%Materials science29.7%Psychology25.9%Pathology23.2%Engineering22.1%Quantum mechanics20.9%

Primary Research Areas

Pharmacology Toxicology and Pharmaceutics Pharmaceutical Science

NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF—

Articles / Year22

Total Citations6

2025

IF—

Articles / Year51

Total Citations8

2024

IF—

Articles / Year34

Total Citations23

2023

IF0

Articles / Year32

Total Citations69

2022

IF—

Articles / Year28

Total Citations52

Year	Impact Factor	Articles / Year	Total Citations
2026	—	22	6
2025	—	51	8
2024	—	34	23
2023	0	32	69
2022	—	28	52
2021	—	27	70
2020	—	28	57
2019	—	23	67
2018	—	27	165
2017	—	31	76
2016	—	25	93
2015	—	33	126

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #24,477Scopus Q4SCImago Profile

Scopus Coverage:1994-2025

•

Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q4

0.162

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4

Citations / Doc (2 years)

0.43

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,362 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations47

3-Year Documents103

Citable Documents98

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate63.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Ceska a Slovenska Farmacie (ISSN: 1210-7816) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Nakladatelske Stredisko CLSJE Purkyne in Czech Republic. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.162 (Q4), an H-index of 19.

The journal enforces rigorous peer evaluation with an annual output of approximately 0 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $2,362 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.